<SEC-DOCUMENT>0001213900-17-005809-index.html : 20170524
<SEC-HEADER>0001213900-17-005809.hdr.sgml : 20170524
<ACCEPTANCE-DATETIME>20170524160529
ACCESSION NUMBER:		0001213900-17-005809
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170523
FILED AS OF DATE:		20170524
DATE AS OF CHANGE:		20170524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1213

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38041
		FILM NUMBER:		17866724

	BUSINESS ADDRESS:	
		STREET 1:		5 AZRIELI CENTER (SQUARE TOWER)
		CITY:			TEL-AVIV
		STATE:			L3
		ZIP:			6702501
		BUSINESS PHONE:		972-3-6167055

	MAIL ADDRESS:	
		STREET 1:		5 AZRIELI CENTER (SQUARE TOWER)
		CITY:			TEL-AVIV
		STATE:			L3
		ZIP:			6702501
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k052417_therapix.htm
<DESCRIPTION>FORM 6-K
<TEXT>
Document 1 - file: f6k052417_therapix.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f6k052417ex99i_therapix.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
Document 2 - file: f6k052417ex99i_therapix.htm

</DOCUMENT>
</SEC-DOCUMENT>